New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
06:00 EDTAMPEAmpio initiated with a Buy at Jefferies
Target $14.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
15:57 EDTAMPEAmpio says Optina benefit not significant vs. placebo, Bloomberg reports
Vaughan Lennox Clift, Chief Regulatory Affairs Officer of Ampio, told Bloomberg in a phone interview that Optina's benefit is not significant versus the placebo. Optina helped a group improve from baseline, Bloomberg adds. Clift also said the FDA may allow narrow sales with a post-market study.
08:08 EDTAMPEAmpio announces positive study results on Optima
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use